Multicentre Study to Record the Mental and Physical Effects of the COVID-19 Pandemic (COBESITY-Study)
International, Prospective Multicentre Study to Record the Mental and Physical Effects of the COVID-19 Pandemic on Two Obese Patient Cohorts Pre- and Post-bariatric Surgery (COBESITY-Study)
1 other identifier
observational
500
1 country
1
Brief Summary
Prospective, international multicenter study to investigate the physical and psychological effects of the COVID-19 pandemic in two obese patient cohorts (BMI ≥ 25 kg/m²) pre- and post-bariatric surgery. In addition, the investigation of country-specific differences will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 19, 2022
CompletedFirst Posted
Study publicly available on registry
March 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedMarch 31, 2022
March 1, 2022
1 year
March 19, 2022
March 28, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
PHQ-4
Impact of the COVID-19 pandemic on mental health (measured by PHQ-4, PSS-10, and EDEQ scores) as well as on physical health (measured by Δ BMI (kg/m\^2) before and after the onset of the pandemic) in two obese patient cohorts pre- and post- bariatric surgery.
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
PSS-10
Impact of the COVID-19 pandemic on mental health (measured by PHQ-4, PSS-10, and EDEQ scores) as well as on physical health (measured by Δ BMI (kg/m\^2) before and after the onset of the pandemic) in two obese patient cohorts pre- and post- bariatric surgery.
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
EDEQ-score
Impact of the COVID-19 pandemic on mental health (measured by PHQ-4, PSS-10, and EDEQ scores) as well as on physical health (measured by Δ BMI (kg/m\^2) before and after the onset of the pandemic) in two obese patient cohorts pre- and post- bariatric surgery.
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
BMI
Impact of the COVID-19 pandemic on mental health (measured by PHQ-4, PSS-10, and EDEQ scores) as well as on physical health (measured by Δ BMI (kg/m\^2) before and after the onset of the pandemic) in two obese patient cohorts pre- and post- bariatric surgery.
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
Secondary Outcomes (3)
Country-specific differences of the physical and psychological impact of the COVID-19 pandemic
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
Differences in psychological impact in obese patients pre- and post-bariatric surgery
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
Differences in psychological impact between obese patients with and without COVID-19 infection
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
Study Arms (2)
Overweight and obese patient cohort
* Age: 18 years and older * BMI ≥ 25kg/m²
Overweight and obese patient cohort with bariatric surgery
* Age: 18 years and older * BMI ≥ 25kg/m² * Status post sleeve or gastric bypass surgery
Eligibility Criteria
Overweight and obese patients with or without bariatric surgery
You may qualify if:
- Overweight and obese patient cohort
- Age: 18 years and older
- BMI ≥ 25kg/m²
- Overweight and obese patient cohort with bariatric surgery
- Age: 18 years and older
- BMI ≥ 25kg/m²
- Status post sleeve or gastric bypass surgery
You may not qualify if:
- Age under 18 years
- Cognitive, mental and/or linguistic limitations to complete the questionnaire independently
- Severe somatic illnesses, such as tumour diseases
- Pregnancy or breastfeeding
- Acute need for treatment due to comorbid mental disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pia Roser, MD
Medical University Hospital Hamburg-Eppendorf
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2022
First Posted
March 31, 2022
Study Start
December 1, 2021
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
March 31, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share